Literature DB >> 3060292

Guide to drug dosage in renal failure.

W M Bennett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3060292     DOI： 10.2165/00003088-198815050-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  271 in total

Review 1.  Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.

Authors:  W H Frishman
Journal:  N Engl J Med       Date:  1982-06-17       Impact factor: 91.245

2.  Artificial organs in acute poisoning: to treat or not to treat with artificial organs.

Authors:  J H Knepshield; J F Winchester; J F Maher; S Garella; T P Gibson; G Seyffart; P R Uldall
Journal:  Trans Am Soc Artif Intern Organs       Date:  1982

Review 3.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

4.  Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.

Authors:  J G Gambertoglio; D P Alexander; S L Barriere
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

5.  Pharmacokinetics of pefloxacin in normal and impaired renal function.

Authors:  D Höffler; I Schäfer; P Koeppe; F Sörgel
Journal:  Arzneimittelforschung       Date:  1988-05

Review 6.  Netilmicin (Netromycin, Schering-Plough).

Authors:  D R Guay
Journal:  Drug Intell Clin Pharm       Date:  1983-02

Review 7.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

8.  Renal disease, age, and oxazepam kinetics.

Authors:  T G Murray; S T Chiang; H H Koepke; B R Walker
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

9.  Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration to a patient with renal failure.

Authors:  G R Aronoff; J J Szwed; R L Nelson; E L Marcus; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Pyridostigmine kinetics with and without renal function.

Authors:  R Cronnelly; D R Stanski; R D Miller; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875
View more
  15 in total

Review 1.  Pharmacokinetics of antimicrobial agents in organ function impairment. A review.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

Review 2.  A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.

Authors:  Thomas D Nolin
Journal:  Semin Dial       Date:  2015-04-08       Impact factor: 3.455

3.  Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states.

Authors:  I W Taylor; T Taylor; I James; G Doyle; G Dorf; A Darragh; L F Chasseaud
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.

Authors:  I Tegeder; F Bremer; R Oelkers; H Schobel; J Schüttler; K Brune; G Geisslinger
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 5.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 6.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 7.  Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin.

Authors:  F Keller; K Erdmann; M Giehl; P Buettner
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

8.  Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.

Authors:  Henrik Agersø; Lotte Seiding Larsen; Anders Riis; Ulf Lövgren; Mats O Karlsson; Thomas Senderovitz
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

9.  The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.

Authors:  M C Rouan; J B Lecaillon; J Godbillon; F Menard; T Darragon; P Meyer; O Kourilsky; D Hillion; J C Aldigier; P Jungers
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 10.  Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations.

Authors:  C F Stewart
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.